A cohort study of vitamin D intake and melanoma risk
- PMID: 19194478
- PMCID: PMC2695831
- DOI: 10.1038/jid.2008.451
A cohort study of vitamin D intake and melanoma risk
Abstract
Data suggest that vitamin D intake may have chemopreventive efficacy against melanoma, but there have been no published epidemiologic studies examining the association between vitamin D intake and melanoma risk in a large prospective cohort. We examined whether dietary and supplemental vitamin D intake was associated with melanoma risk among 68,611 men and women who were participants of the Vitamins and Lifestyle cohort study. Participants reported dietary vitamin D intake over the past year and 10-year use of multivitamin and individual vitamin D supplements on a baseline questionnaire. After follow-up through 2006, 455 incident melanomas were identified through linkage to the Surveillance, Epidemiology, and End Results cancer registry. Cox proportional hazards regression models were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for vitamin D intake after adjustment for melanoma risk factors. Compared with the lowest quartile, we did not detect a risk reduction of melanoma in the highest quartiles of dietary vitamin D intake (RR=1.31, CI=0.94-1.82), 10-year average supplemental vitamin D intake (RR=1.13, CI=0.89-1.43), or combined dietary and supplemental intake (1.05, CI=0.79-1.40). In this large prospective cohort, we did not find an association between vitamin D intake and melanoma risk.
Conflict of interest statement
CONFLICT OF INTEREST
The authors state no conflict of interest.
Comment in
-
Vitamin D intake and melanoma risk.J Invest Dermatol. 2009 Jul;129(7):1598. doi: 10.1038/jid.2009.147. J Invest Dermatol. 2009. PMID: 19521403 No abstract available.
References
-
- American Cancer Society. Cancer Facts and Figures 2007. Atlanta: American Cancer Society; 2007.
-
- Austin H, Hill HA, Flanders WD, Greenberg RS. Limitations in the application of case-control methodology. Epidemiol Rev. 1994;16:65–76. - PubMed
-
- Colston K, Colston MJ, Feldman D. 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology. 1981;108:1083–6. - PubMed
-
- Cornwell ML, Comstock GW, Holick MF, Bush TL. Prediagnostic serum levels of 1,25-dihydroxyvitamin D and malignant melanoma. Photodermatol Photoimmunol Photomed. 1992;9:109–12. - PubMed
-
- Eisman JA, Barkla DH, Tutton PJ. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res. 1987;47:21–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
